2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Pain, Postoperative
19
Breast Neoplasms
16
Pain
9
Agnosia
8
Lung Neoplasms
6
Prostatic Neoplasms
5
Neoplasms
5
Stomach Neoplasms
4
Colorectal Neoplasms
4
Postoperative Complications
3
Colonic Neoplasms
3
Supratentorial Neoplasms
2
Meningioma
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Sleep Deprivation
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pain, Intractable
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Oropharyngeal Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Malignant Neoplasms of Male Genital Organs
1
Liver Neoplasms
1
Liver Diseases
1
Interventions
aldesleukin
43
Sunitinib
42
Cyclophosphamide
30
Nivolumab
29
pembrolizumab
27
Everolimus
27
Interferon-alpha
25
Bevacizumab
23
Sorafenib
22
Interleukin-2
20
fludarabine phosphate
19
Radiotherapy
18
Ipilimumab
18
Filgrastim
18
Axitinib
18
Gene Expression Profiling
16
Peripheral Blood Stem Cell Transplantation
15
Gemcitabine
15
cabozantinib
14
Radiosurgery
13
fludarabine
11
Doxorubicin
11
Carboplatin
11
Blood Specimen Collection
11
temsirolimus
10
atezolizumab
9
Immunohistochemistry
9
Etoposide
9
Chemotherapy, Adjuvant
9
sargramostim
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Ropivacaine
×
Clear all
NCT04085237
2026-06-04
ESPB
McMaster University
Phase NA
Terminated
10 enrolled